Jefferson Miley, MD
Vascular Neurology · Austin, TXNPI 1922292259
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 60.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $17,687 and has fallen 94.2% since, to $1,028 in 2025. Among vascular neurology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $226.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$17K
- Medtronic$5K
- Abbott$2K
- Microvention, Inc.$2K
- Imperative Care, Inc$631
- Johnson & Johnson$402
- plus $716 from 7 others
What the payments were for
- Consulting fees$2,0007%
- Speaking & faculty fees$14,77553%
- Travel & lodging$2,0167%
- Food & beverage$9,34733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 59 | $17,013 |
| Medtronic(3 entities) | 23 | $5,490 |
| Abbott | 6 | $2,072 |
| Microvention, Inc. | 18 | $1,813 |
| Imperative Care, Inc | 5 | $631 |
| Johnson & Johnson | 3 | $402 |
| Surmodics, Inc. | 2 | $265 |
| Medical Device Business Services, Inc. | 2 | $149 |
| Pfizer | 1 | $81 |
| Scientia Vascular | 1 | $80 |
| Genentech, Inc. | 1 | $77 |
| AbbVie | 2 | $34 |
| Route 92 Medical, Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$7,433
- ACE$5,570
- Reveal LINQ$2,196
- Penumbra Coil 400$2,140
- AMPLATZER Occluders$2,000
- Smart Coil$1,200
- Arctic Front$1,060
- Pipeline$645
- WEB Aneurysm Embolization System$547
- Penumbra Jet 7$510
- STENT$402
- HYDROSOFT ADVANCED$385
- RED 72$348
- ZOOM 88-T LARGE DISTAL PLATFORM$297
- CEREBASE$289
- TRUFILL$282
- LVIS JUNIOR$220
- Pounce Thrombectomy System$191
- Pounce Venous Thrombectomy System$191
- Sublime 014 Rx PTA Balloon Dilatation Catheter$191
How this compares
$28,138 in reported general payments places this provider in the 90th percentile of 76 vascular neurology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 14 | $261 |
| ClopidogrelClopidogrel Bisulfate | 23 | $251 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Austin
- Steven WarachAustin$32K
- Hamidreza SaberAustin$22K
- Samantha MillerAustin$11K
- Omar Kass-HoutAustin$6K
- Manzure MawlaAustin$191
- Matthew PadrickAustin$148
- Ameer HassanHarlingen$1M
- John VolpiHouston$407K
- Lee BirnbaumSan Antonio$195K
- Amrou SarrajHouston$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.